Current FDA-Related Drug Information

Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals

Baker, Danial E. PharmD, FASHP, FASCP

^*Director, Drug Information Center, College of Pharmacy, Washington State University Spokane, PO Box 1495, Spokane, WA 99210-1495.

Hospital Pharmacy 48(6):p 512-519, June 2013. | DOI: 10.1310/hpj4806-512

This monthly feature will help readers keep current on new drugs, new indications, dosage forms, and safety-related changes in labeling or use. Efforts have been made to ensure the accuracy of this information; however, if there are any questions, please let me know at [email protected].